Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia.
about
Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated CandidiasisDetermination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection modelIn vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin.Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacinGeneric vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection modelTherapeutic equivalence requires pharmaceutical, pharmacokinetic, and pharmacodynamic identities: true bioequivalence of a generic product of intravenous metronidazole.Nephrotoxicity comparison of two commercially available generic vancomycin products.Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam.Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem.Vancomycin dosing and monitoring 2 years after the guidelines.Interplay of the Quality of Ciprofloxacin and Antibiotic Resistance in Developing Countries.Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator.
P2860
Q27347943-218AEFF0-6F5A-42F0-9CB2-6AB71D9EFC52Q28474000-75579B7C-602F-413B-BB39-A21C72BD6853Q33595346-F859BE0D-5AFC-4FA2-A496-F76CA297113FQ34922857-34E887DD-AC67-4BF0-A2A8-FB469C82CCADQ35666429-04A38FF7-2DAE-491C-B238-FDE05342D6FCQ35941429-C6CE952D-F1CD-4418-A088-60989D873D6BQ35960929-86EB82FA-7A41-4D4D-B056-B0CB58355675Q36020757-6206FDD9-D39D-4ADF-81D8-D5218A101CE7Q37544589-AA39D794-D385-4863-85B3-BC3FB90528DFQ37892556-0B8B2FB3-E0A2-4FE4-BF4F-625DEB655986Q40067159-F2AB32D6-6E6C-4F97-B998-E77648C82F10Q41890029-DF6B83F4-4E92-4FF1-897F-A05AEE9673A7
P2860
Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Potential therapeutic failure ...... SA peritonitis and bacteremia.
@en
Potential therapeutic failure ...... SA peritonitis and bacteremia.
@nl
type
label
Potential therapeutic failure ...... SA peritonitis and bacteremia.
@en
Potential therapeutic failure ...... SA peritonitis and bacteremia.
@nl
prefLabel
Potential therapeutic failure ...... SA peritonitis and bacteremia.
@en
Potential therapeutic failure ...... SA peritonitis and bacteremia.
@nl
P2093
P1433
P1476
Potential therapeutic failure ...... RSA peritonitis and bacteremia
@en
P2093
Juan C Cataño
Maria Agudelo
Omar Vesga
P304
P356
10.1016/J.JINF.2009.08.005
P577
2009-08-19T00:00:00Z